SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway

Zhiwei Xue(Shandong University), Xinyu Wang(China Pharmaceutical University)
BMC Cancer
June 26, 2023
Cited by 16


Related Papers